cached image

Bé Wieringa - Publications

Affiliations: 
Cell Biology Radboud University Nijmegen, Nijmegen, Gelderland, Netherlands 
Area:
Energy & Redox Metabolism
Website:
http://ncmls.nl/people/wieringa/

116/275 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 André LM, van Cruchten RTP, Willemse M, Bezstarosti K, Demmers JAA, van Agtmaal EL, Wansink DG, Wieringa B. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG) Repeat. International Journal of Molecular Sciences. 20. PMID 31766224 DOI: 10.3390/ijms20225685  0.357
2019 van Cruchten RTP, Wieringa B, Wansink DG. Expanded CUG repeats in transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences. Rna (New York, N.Y.). 25: 481-495. PMID 30700578 DOI: 10.1261/rna.068940.118  0.31
2018 André LM, Ausems CRM, Wansink DG, Wieringa B. Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy. Frontiers in Neurology. 9: 368. PMID 29892259 DOI: 10.3389/fneur.2018.00368  0.305
2017 Gudde AEEG, van Kessel IDG, André LM, Wieringa B, Wansink DG. Trinucleotide-repeat expanded and normal DMPK transcripts contain unusually long poly(A) tails despite differential nuclear residence. Biochimica Et Biophysica Acta. PMID 28435090 DOI: 10.1016/j.bbagrm.2017.04.002  0.305
2017 van Agtmaal EL, André LM, Willemse M, Cumming SA, van Kessel ID, van den Broek WJ, Gourdon G, Furling D, Mouly V, Monckton DG, Wansink DG, Wieringa B. CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing. Molecular Therapy : the Journal of the American Society of Gene Therapy. 25: 24-43. PMID 28129118 DOI: 10.1016/j.ymthe.2016.10.014  0.36
2017 Gudde AE, van Heeringen SJ, de Oude AI, van Kessel ID, Estabrook J, Wang ET, Wieringa B, Wansink DG. Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat. Rna Biology. 0. PMID 28102759 DOI: 10.1080/15476286.2017.1279787  0.3
2016 Gudde AE, González-Barriga A, van den Broek WJ, Wieringa B, Wansink DG. A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle. Human Molecular Genetics. PMID 26908607 DOI: 10.1093/hmg/ddw042  0.339
2015 González-Barriga A, Kranzen J, Croes HJ, Bijl S, van den Broek WJ, van Kessel ID, van Engelen BG, van Deutekom JC, Wieringa B, Mulders SA, Wansink DG. Cell membrane integrity in myotonic dystrophy type 1: implications for therapy. Plos One. 10: e0121556. PMID 25799359 DOI: 10.1371/journal.pone.0121556  0.313
2014 González-Barriga A, Kranzen J, Croes HJE, Broek WJAvd, Engelen BGMv, Deutekom JCTv, Wieringa B, Mulders SAM, Wansink DG. G.P.131: Cell membrane integrity in myotonic dystrophy type 1: Implications for therapy Neuromuscular Disorders. 24: 840. DOI: 10.1016/J.Nmd.2014.06.161  0.32
2013 González-Barriga A, Mulders SA, van de Giessen J, Hooijer JD, Bijl S, van Kessel ID, van Beers J, van Deutekom JC, Fransen JA, Wieringa B, Wansink DG. Design and analysis of effects of triplet repeat oligonucleotides in cell models for myotonic dystrophy. Molecular Therapy. Nucleic Acids. 2: e81. PMID 23511335 DOI: 10.1038/mtna.2013.9  0.32
2013 Nabuurs CI, Choe CU, Veltien A, Kan HE, van Loon LJ, Rodenburg RJ, Matschke J, Wieringa B, Kemp GJ, Isbrandt D, Heerschap A. Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake. The Journal of Physiology. 591: 571-92. PMID 23129796 DOI: 10.1113/Jphysiol.2012.241760  0.303
2012 Valsecchi F, Monge C, Forkink M, de Groof AJ, Benard G, Rossignol R, Swarts HG, van Emst-de Vries SE, Rodenburg RJ, Calvaruso MA, Nijtmans LG, Heeman B, Roestenberg P, Wieringa B, Smeitink JA, et al. Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts. Biochimica Et Biophysica Acta. 1817: 1925-36. PMID 22430089 DOI: 10.1016/J.Bbabio.2012.03.006  0.334
2012 Gerrits L, Overheul GJ, Derks RC, Wieringa B, Hendriks WJ, Wansink DG. Gene duplication and conversion events shaped three homologous, differentially expressed myosin regulatory light chain (MLC2) genes. European Journal of Cell Biology. 91: 629-39. PMID 22425609 DOI: 10.1016/j.ejcb.2012.02.001  0.353
2011 Mulders SA, van Horssen R, Gerrits L, Bennink MB, Pluk H, de Boer-van Huizen RT, Croes HJ, Wijers M, van de Loo FA, Fransen J, Wieringa B, Wansink DG. Abnormal actomyosin assembly in proliferating and differentiating myoblasts upon expression of a cytosolic DMPK isoform. Biochimica Et Biophysica Acta. 1813: 867-77. PMID 21295081 DOI: 10.1016/j.bbamcr.2011.01.024  0.35
2009 Oude Ophuis RJ, Wijers M, Bennink MB, van de Loo FA, Fransen JA, Wieringa B, Wansink DG. A tail-anchored myotonic dystrophy protein kinase isoform induces perinuclear clustering of mitochondria, autophagy, and apoptosis. Plos One. 4: e8024. PMID 19946639 DOI: 10.1371/journal.pone.0008024  0.35
2009 Mulders SA, van den Broek WJ, Wheeler TM, Croes HJ, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, Wieringa B, Wansink DG. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 106: 13915-20. PMID 19667189 DOI: 10.1073/pnas.0905780106  0.314
2009 Oude Ophuis RJ, Mulders SA, van Herpen RE, van de Vorstenbosch R, Wieringa B, Wansink DG. DMPK protein isoforms are differentially expressed in myogenic and neural cell lineages. Muscle & Nerve. 40: 545-55. PMID 19626675 DOI: 10.1002/mus.21352  0.351
2009 Streijger F, Pluk H, Oerlemans F, Beckers G, Bianco AC, Ribeiro MO, Wieringa B, Van der Zee CE. Mice lacking brain-type creatine kinase activity show defective thermoregulation. Physiology & Behavior. 97: 76-86. PMID 19419668 DOI: 10.1016/j.physbeh.2009.02.003  0.305
2009 Kan HE, Veltien A, Arnts H, Nabuurs CI, Luijten B, de Haan A, Wieringa B, Heerschap A. Gated dynamic 31P MRS shows reduced contractile phosphocreatine breakdown in mice deficient in cytosolic creatine kinase and adenylate kinase. Nmr in Biomedicine. 22: 523-31. PMID 19156695 DOI: 10.1002/Nbm.1364  0.32
2007 Renema WK, Kan HE, Wieringa B, Heerschap A. In vivo magnetic resonance spectroscopy of transgenic mouse models with altered high-energy phosphoryl transfer metabolism. Nmr in Biomedicine. 20: 448-67. PMID 17274105 DOI: 10.1002/Nbm.1117  0.314
2006 van Herpen RE, Tjeertes JV, Mulders SA, Oude Ophuis RJ, Wieringa B, Wansink DG. Coiled-coil interactions modulate multimerization, mitochondrial binding and kinase activity of myotonic dystrophy protein kinase splice isoforms. The Febs Journal. 273: 1124-36. PMID 16519679 DOI: 10.1111/j.1742-4658.2006.05138.x  0.309
2005 van Herpen RE, Oude Ophuis RJ, Wijers M, Bennink MB, van de Loo FA, Fransen J, Wieringa B, Wansink DG. Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors. Molecular and Cellular Biology. 25: 1402-14. PMID 15684391 DOI: 10.1128/MCB.25.4.1402-1414.2005  0.348
2004 O'Cochlain DF, Perez-Terzic C, Reyes S, Kane GC, Behfar A, Hodgson DM, Strommen JA, Liu XK, van den Broek W, Wansink DG, Wieringa B, Terzic A. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Human Molecular Genetics. 13: 2505-18. PMID 15317754 DOI: 10.1093/Hmg/Ddh266  0.372
2004 Janssen E, Kuiper J, Hodgson D, Zingman LV, Alekseev AE, Terzic A, Wieringa B. Two structurally distinct and spatially compartmentalized adenylate kinases are expressed from the AK1 gene in mouse brain. Molecular and Cellular Biochemistry. 256: 59-72. PMID 14977170 DOI: 10.1023/B:Mcbi.0000009859.15267.Db  0.342
2004 Dzeja PP, Terzic A, Wieringa B. Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice. Molecular and Cellular Biochemistry. 256: 13-27. PMID 14977167 DOI: 10.1023/B:Mcbi.0000009856.23646.38  0.315
2003 Wansink DG, van Herpen RE, Coerwinkel-Driessen MM, Groenen PJ, Hemmings BA, Wieringa B. Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization. Molecular and Cellular Biology. 23: 5489-501. PMID 12897125 DOI: 10.1128/MCB.23.16.5489-5501.2003  0.349
2003 Janssen E, Terzic A, Wieringa B, Dzeja PP. Impaired intracellular energetic communication in muscles from creatine kinase and adenylate kinase (M-CK/AK1) double knock-out mice. The Journal of Biological Chemistry. 278: 30441-9. PMID 12730234 DOI: 10.1074/Jbc.M303150200  0.317
2003 Westerlaken JH, Van der Zee CE, Peters W, Wieringa B. The DMWD protein from the myotonic dystrophy (DM1) gene region is developmentally regulated and is present most prominently in synapse-dense brain areas. Brain Research. 971: 116-27. PMID 12691844 DOI: 10.1016/S0006-8993(03)02430-2  0.336
2003 Janssen E, de Groof A, Wijers M, Fransen J, Dzeja PP, Terzic A, Wieringa B. Adenylate kinase 1 deficiency induces molecular and structural adaptations to support muscle energy metabolism. The Journal of Biological Chemistry. 278: 12937-45. PMID 12562761 DOI: 10.1074/jbc.M211465200  0.343
2002 Makarchikov AF, Wins P, Janssen E, Wieringa B, Grisar T, Bettendorff L. Adenylate kinase 1 knockout mice have normal thiamine triphosphate levels. Biochimica Et Biophysica Acta. 1592: 117-21. PMID 12379473 DOI: 10.1016/S0167-4889(02)00277-X  0.318
2002 van den Broek WJ, Nelen MR, Wansink DG, Coerwinkel MM, te Riele H, Groenen PJ, Wieringa B. Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Human Molecular Genetics. 11: 191-8. PMID 11809728 DOI: 10.1093/Hmg/11.2.191  0.363
2001 de Groof AJ, Smeets B, Groot Koerkamp MJ, Mul AN, Janssen EE, Tabak HF, Wieringa B. Changes in mRNA expression profile underlie phenotypic adaptations in creatine kinase-deficient muscles. Febs Letters. 506: 73-8. PMID 11591374 DOI: 10.1016/S0014-5793(01)02879-4  0.323
2001 de Groof AJ, Oerlemans FT, Jost CR, Wieringa B. Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles. Muscle & Nerve. 24: 1188-96. PMID 11494272 DOI: 10.1002/mus.1131  0.312
2000 Janssen E, Dzeja PP, Oerlemans F, Simonetti AW, Heerschap A, de Haan A, Rush PS, Terjung RR, Wieringa B, Terzic A. Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. The Embo Journal. 19: 6371-81. PMID 11101510 DOI: 10.1093/Emboj/19.23.6371  0.317
2000 Pucar D, Janssen E, Dzeja PP, Juranic N, Macura S, Wieringa B, Terzic A. Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress. The Journal of Biological Chemistry. 275: 41424-9. PMID 11006295 DOI: 10.1074/jbc.M007903200  0.308
2000 Groenen PJTA, Wansink DG, Coerwinkel M, Van Den Broek W, Jansen G, Wieringa B. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties Human Molecular Genetics. 9: 605-616. PMID 10699184 DOI: 10.1093/Hmg/9.4.605  0.393
1999 Van Den Maagdenberg AMJM, Bachner D, Schepens JTG, Peters W, Fransen JAM, Wieringa B, Hendriks WJAJ. The mouse Ptprr gene encodes two protein tyrosine phosphatases, PTP-SL and PTPBR7, that display distinct patterns of expression during neural development European Journal of Neuroscience. 11: 3832-3844. PMID 10583472 DOI: 10.1046/j.1460-9568.1999.00802.x  0.371
1999 ten Dam GB, Wieringa B, Poels LG. Alternative splicing of CD45 pre-mRNA is uniquely obedient to conditions in lymphoid cells. Biochimica Et Biophysica Acta. 1446: 317-33. PMID 10524206 DOI: 10.1016/S0167-4781(99)00119-0  0.315
1998 Groenen P, Wieringa B. Expanding complexity in myotonic dystrophy Bioessays. 20: 901-912. PMID 9872056 DOI: 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0  0.404
1998 Steeghs K, Oerlemans F, De Haan A, Heerschap A, Verdoodt L, De Bie M, Ruitenbeek W, Benders A, Jost C, Van Deursen J, Tullson P, Terjung R, Jap P, Jacob W, Pette D, ... Wieringa B, et al. Cytoarchitectural and metabolic adaptations in muscles with mitochondrial and cytosolic creatine kinase deficiencies Molecular and Cellular Biochemistry. 184: 183-194. PMID 9746321 DOI: 10.1007/978-1-4615-5653-4_14  0.326
1998 Boehm E, Veksler V, Mateo P, Lenoble C, Wieringa B, Ventura-Clapier R. Maintained coupling of oxidative phosphorylation to creatine kinase activity in sarcomeric mitochondrial creatine kinase-deficient mice Journal of Molecular and Cellular Cardiology. 30: 901-912. PMID 9618231 DOI: 10.1006/jmcc.1998.0692  0.301
1998 Tullson PC, Rush JWE, Wieringa B, Terjung RL. Alterations in AMP deaminase activity and kinetics in skeletal muscle of creatine kinase-deficient mice American Journal of Physiology - Cell Physiology. 274: C1411-C1416. PMID 9612229 DOI: 10.1152/Ajpcell.1998.274.5.C1411  0.33
1998 De Bruin WCC, Te Morsche RHM, Wagenmans MJM, Alferink JC, Townsend AJ, Wieringa B, Peters WHM. Identification of a novel murine glutathione S-transferase class mu gene Biochemical Journal. 330: 623-626. PMID 9480867 DOI: 10.1042/Bj3300623  0.363
1997 Schaapveld RQ, Schepens JT, Robinson GW, Attema J, Oerlemans FT, Fransen JA, Streuli M, Wieringa B, Hennighausen L, Hendriks WJ. Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity. Developmental Biology. 188: 134-46. PMID 9245518 DOI: 10.1006/dbio.1997.8630  0.335
1997 van den Hurk JA, Hendriks W, van de Pol DJ, Oerlemans F, Jaissle G, Rüther K, Kohler K, Hartmann J, Zrenner E, van Bokhoven H, Wieringa B, Ropers HH, Cremers FP. Mouse choroideremia gene mutation causes photoreceptor cell degeneration and is not transmitted through the female germline. Human Molecular Genetics. 6: 851-8. PMID 9175730 DOI: 10.1093/Hmg/6.6.851  0.644
1997 Steeghs K, Benders A, Oerlemans F, De Haan A, Heerschap A, Ruitenbeek W, Jost C, Van Deursen J, Perryman B, Pette D, Brückwilder M, Koudijs J, Paul J, Veerkamp J, Wieringa B. Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies Cell. 89: 93-103. PMID 9094718 DOI: 10.1016/S0092-8674(00)80186-5  0.316
1996 Van Den Maagdenberg AMJM, Olde Weghuis D, Rijss J, Merkx GF, Wieringa B, Geurts Van Kessel A, Hendriks WJAJ. The gene (PTPN13) encoding the protein tyrosine phosphatase PTP-BL/PTP-BAS is located in mouse chromosome region 5E/F and human chromosome region 4q21 Cytogenetics and Cell Genetics. 74: 153-155. PMID 8893825 DOI: 10.1159/000134405  0.383
1996 Berger W, van de Pol D, Bächner D, Oerlemans F, Winkens H, Hameister H, Wieringa B, Hendriks W, Ropers HH. An animal model for Norrie disease (ND): gene targeting of the mouse ND gene. Human Molecular Genetics. 5: 51-9. PMID 8789439 DOI: 10.1093/hmg/5.1.51  0.542
1996 Jansen G, Groenen PJ, Bächner D, Jap PH, Coerwinkel M, Oerlemans F, van den Broek W, Gohlsch B, Pette D, Plomp JJ, Molenaar PC, Nederhoff MG, van Echteld CJ, Dekker M, Berns A, ... ... Wieringa B, et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genetics. 13: 316-24. PMID 8673131 DOI: 10.1038/ng0796-316  0.363
1996 Van Den Maagdenberg AMJM, Weghuis DO, Rijss J, Van De Wetering RAC, Wieringa B, Van Geurts Kessel A, Hendriks WJAJ. Assignment of the human gene for receptor-type protein tyrosine phosphatase IA-2 (PTPRN) to chromosome region 2q35→q36.1 and identification of an intragenic genetic marker Cytogenetics and Cell Genetics. 73: 145-148. PMID 8646884 DOI: 10.1159/000134327  0.422
1996 Hendriks W, Brugman C, Richter KH, Van Hooijdonk C, Schepens J, Schalkwijk J, Wieringa B. Protein-tyrosine phosphatases expressed in mouse epidermal keratinocytes Journal of Investigative Dermatology. 106: 972-976. PMID 8618060 DOI: 10.1111/1523-1747.Ep12338472  0.328
1995 Hendriks W, Schepens J, Bachner D, Rijss J, Zeeuwen P, Zechner U, Hameister H, Wieringa B. Molecular cloning of a mouse epithelial protein-tyrosine phosphatase with similarities to submembranous proteins Journal of Cellular Biochemistry. 59: 418-430. PMID 8749712 DOI: 10.1002/jcb.240590403  0.341
1995 Van den Maagdenberg AMJM, Van den Hurk HH, Weghuis DO, Wieringa B, Van Kessel AG, Hendriks WJAJ. Assignment of the human protein tyrosine phosphatase epsilon (PTPRE) gene to chromosome 10q26 by fluorescence in situ hybridization Genomics. 30: 128-129. PMID 8595895 DOI: 10.1006/geno.1995.0026  0.377
1995 De Bruijn DRH, Oerlemans F, Hendriks W, Baats E, Ploemacher R, Wieringa B, Van Kessel AG. Normal development, growth and reproduction in cellular retinoic acid binding protein-I (CRABPI) null mutant mice Differentiation. 58: 141-148. PMID 7890139 DOI: 10.1046/j.1432-0436.1995.5820141.x  0.327
1995 Hendriks W, Schepens J, Brugman C, Zeeuwen P, Wieringa B. A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain Biochemical Journal. 305: 499-504. PMID 7832766 DOI: 10.1042/Bj3050499  0.335
1995 Schaapveld RQJ, Van den Maagdenberg AMJM, Schepens JTG, Weghuis DO, Van Kessel AG, Wieringa B, Hendriks WJAJ. The mouse gene Ptprf encoding the leukocyte common antigen-related molecule LAR: Cloning, characterization, and chromosomal localization Genomics. 27: 124-130. PMID 7665159 DOI: 10.1006/geno.1995.1014  0.422
1995 Jansen G, Bachner D, Coerwinkel M, Wormskamp N, Hameister H, Wieringa B. Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus Human Molecular Genetics. 4: 843-852. PMID 7633444 DOI: 10.1093/Hmg/4.5.843  0.406
1995 Steeghs K, Oerlemans F, Wieringa B. Mice deficient in ubiquitous mitochondrial creatine kinase are viable and fertile Bba - Bioenergetics. 1230: 130-138. PMID 7619831 DOI: 10.1016/0005-2728(95)00044-J  0.333
1995 Steeghs K, Peters W, Bruckwilder M, Croes H, Van Alewijk D, Wieringa B. Mouse ubiquitous mitochondrial creatine kinase: Gene organization and consequences from inactivation in mouse embryonic stem cells Dna and Cell Biology. 14: 539-553. PMID 7598809 DOI: 10.1089/Dna.1995.14.539  0.397
1995 Van Ree JH, Van Den Broek WJJA, Van Der Zee A, Dahlmans VEH, Wieringa B, Frants RR, Havekes LM, Hofker MH. Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: Effects on mRNA expression levels of gene cluster members Human Molecular Genetics. 4: 1403-1409. PMID 7581381 DOI: 10.1093/Hmg/4.8.1403  0.373
1994 Hendriks W, Brugman C, Schepens J, Wieringa B. Rapid assessment of protein-tyrosine phosphatase expression levels by RT-PCR with degenerate primers Molecular Biology Reports. 19: 105-108. PMID 8072490 DOI: 10.1007/BF00997155  0.335
1994 Iles DE, Lehmann-Horn F, Scherer SW, Tsui LC, Olde Weghuis D, Suljkerbuijk RF, Heytens L, Mikala G, Schwartz A, Ellis FR, Stewart AD, Deufel T, Wieringa B. Localization of the gene encoding the α2/δ-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families Human Molecular Genetics. 3: 969-975. PMID 7951247 DOI: 10.1093/Hmg/3.6.969  0.392
1994 Steeghs K, Merkx G, Wieringa B. The ubiquitous mitochondrial creatine kinase gene maps to a conserved region on human chromosome 15q15 and mouse chromosome 2 bands F1-F3 Genomics. 24: 193-195. PMID 7896282 DOI: 10.1006/geno.1994.1604  0.356
1993 Jansen G, Coerwinkel-Driessen M, Nillesen W, Brunner H, Wieringa B. Dinucleotide repeat polymorphism at locus D19S207, close to the myotonic dystrophy (DM) gene Human Molecular Genetics. 2: 333. PMID 8499928 DOI: 10.1093/Hmg/2.3.333  0.527
1993 Mahadevan MS, Amemiya C, Jansen G, Sabourin L, Baird S, Neville CE, Wormskamp N, Segers B, Batzer M, Lamerdin J, De Jong P, Wieringa B, Korneluk RG. Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene Human Molecular Genetics. 2: 299-304. PMID 8499920 DOI: 10.1093/Hmg/2.3.299  0.392
1993 Brunner HG, Jansen G, Nillesen W, Nelen MR, de Die CE, Höweler CJ, van Oost BA, Wieringa B, Ropers HH, Smeets HJ. Brief report: reverse mutation in myotonic dystrophy. The New England Journal of Medicine. 328: 476-80. PMID 8421477 DOI: 10.1056/NEJM199302183280705  0.515
1993 Jansen G, Bartolomei M, Kalscheuer V, Merkx G, Wormskamp N, Mariman E, Smeets D, Ropers HH, Wieringa B. No imprinting involved in the expression of DM-kinase mRNAs in mouse and human tissues Human Molecular Genetics. 2: 1221-1227. PMID 8401505 DOI: 10.1093/HMG/2.8.1221  0.519
1993 van Deursen J, Heerschap A, Oerlemans F, Rultenbeek W, Jap P, ter Laak H, Wieringa B. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity Cell. 74: 621-631. PMID 8358791 DOI: 10.1016/0092-8674(93)90510-W  0.315
1993 Brunner HG, Höweler CJ, Smeets HJ, Wieringa B. [An unstable mutation as cause of myotonic dystrophy]. Nederlands Tijdschrift Voor Geneeskunde. 137: 2468-72. PMID 8272119  0.355
1993 Brunner HG, Brüggenwirth HT, Nillesen W, Jansen G, Hamel BC, Hoppe RL, de Die CE, Höweler CJ, van Oost BA, Wieringa B. Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). American Journal of Human Genetics. 53: 1016-23. PMID 8213829  0.393
1992 Deursen Jv, Schepens J, Peters W, Meijer D, Grosveld G, Hendriks W, Wieringa B. Genetic variability of the murine creatine kinase B gene locus and related pseudogenes in different inbred strains of mice. Genomics. 12: 340-349. PMID 1740343 DOI: 10.1016/0888-7543(92)90383-4  0.394
1992 Jansen G, de Jong PJ, Amemiya C, Aslanidis C, Shaw DJ, Harley HG, Brook JD, Fenwick R, Korneluk RG, Tsilfidis C, Shutler G, Hermens R, Wormskamp NGM, Smeets HJM, Wieringa B. Physical and genetic characterization of the distal segment of the myotonic dystrophy area on 19q Genomics. 13: 509-517. PMID 1639379 DOI: 10.1016/0888-7543(92)90118-C  0.42
1992 Schepens J, Zeeuwen P, Wieringa B, Hendriks W. Identification and typing of members of the protein-tyrosine phosphatase gene family expressed in mouse brain Molecular Biology Reports. 16: 241-248. PMID 1454056 DOI: 10.1007/BF00419663  0.353
1992 Brunner HG, Nillesen W, van Oost BA, Jansen G, Wieringa B, Ropers HH, Smeets HJ. Presymptomatic diagnosis of myotonic dystrophy. Journal of Medical Genetics. 29: 780-4. PMID 1453426  0.609
1992 Smeets HJ, Nillesen WM, Los F, Busch HF, Korneluk RG, Wieringa B, Brunner HG. Prenatal diagnosis of myotonic dystrophy by direct mutation analysis. Lancet (London, England). 340: 237-8. PMID 1353153 DOI: 10.1016/0140-6736(92)90500-3  0.435
1991 Van Deursen J, Lovell-Badge R, Oerlemans F, Schepens J, Wieringa B. Modulation of gene activity by consecutive gene targeting of one creatine kinase M allele in mouse embryonic stem cells Nucleic Acids Research. 19: 2637-2643. PMID 2041741 DOI: 10.1093/Nar/19.10.2637  0.397
1991 Brook JD, Knight SJL, Roberts SH, Harley HG, Walsh KV, Rundle SA, Freyne K, Koch MC, Epstein ND, Wieringa B, Schonk D, Smeets H, Haddingham K, Siciliano MJ, Palmer DK, et al. The physical map of chromosome arm 19q: some new assignments, confirmations and re-assessments Human Genetics. 87: 65-72. PMID 2037284 DOI: 10.1007/BF01213095  0.356
1991 Brunner HG, Spaans F, Smeets HJ, Coerwinkel-Driessen M, Hulsebos T, Wieringa B, Ropers HH. Genetic linkage with chromosome 19 but not chromosome 17 in a family with myotonic dystrophy associated with hereditary motor and sensory neuropathy. Neurology. 41: 80-4. PMID 1985299 DOI: 10.1212/Wnl.41.1.80  0.598
1991 Brunner HG, Smeets HJ, Nillesen W, van Oost BA, van den Biezenbos JB, Joosten EM, Pinckers AJ, Hamel BC, Theeuwes AG, Wieringa B. Myotonic dystrophy. Predictive value of normal results on clinical examination. Brain : a Journal of Neurology. 114: 2303-11. PMID 1933246 DOI: 10.1093/Brain/114.5.2303  0.522
1991 Smeets HJ, Hermens R, Brunner HG, Ropers HH, Wieringa B. Identification of variable simple sequence motifs in 19q13.2-qter: markers for the myotonic dystrophy locus. Genomics. 9: 257-63. PMID 1840564 DOI: 10.1016/0888-7543(91)90250-I  0.658
1991 Mariman E, Wieringa B. Expression of the gene encoding human brain creatine kinase depends on sequences immediately following the transcription start point. Gene. 102: 205-212. PMID 1840537 DOI: 10.1016/0378-1119(91)90079-Q  0.373
1990 Diergaarde PJ, Wieringa B, Bleeker-Wagemakers EM, Sims KB, Breakefield XO, Ropers HH. Physical fine-mapping of a deletion spanning the Norrie gene. Human Genetics. 84: 22-6. PMID 2606473 DOI: 10.1007/BF00210665  0.402
1990 Cremers FP, Sankila EM, Brunsmann F, Jay M, Jay B, Wright A, Pinckers AJ, Schwartz M, van de Pol DJ, Wieringa B. Deletions in patients with classical choroideremia vary in size from 45 kb to several megabases. American Journal of Human Genetics. 47: 622-8. PMID 2220804  0.535
1990 Cremers FP, van de Pol DJ, van Kerkhoff LP, Wieringa B, Ropers HH. Cloning of a gene that is rearranged in patients with choroideraemia. Nature. 347: 674-7. PMID 2215697 DOI: 10.1038/347674A0  0.642
1990 Cremers FP, Brunsmann F, Berger W, van Kerkhoff EP, van de Pol TJ, Wieringa B, Pawlowitzki IH, Ropers HH. Cloning of the breakpoints of a deletion associated with choroidermia. Human Genetics. 86: 61-4. PMID 1979308 DOI: 10.1007/Bf00205174  0.65
1990 van de Pol TJ, Cremers FP, Brohet RM, Wieringa B, Ropers HH. Derivation of clones from the choroideremia locus by preparative field inversion gel electrophoresis. Nucleic Acids Research. 18: 725-31. PMID 1969148 DOI: 10.1093/NAR/18.4.725  0.633
1989 Cremers FP, van de Pol DJ, Diergaarde PJ, Wieringa B, Nussbaum RL, Schwartz M, Ropers HH. Physical fine mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. Genomics. 4: 41-6. PMID 2914708 DOI: 10.1016/0888-7543(89)90312-1  0.66
1989 Cremers FP, van de Pol DJ, Wieringa B, Collins FS, Sankila EM, Siu VM, Flintoff WF, Brunsmann F, Blonden LA, Ropers HH. Chromosomal jumping from the DXS165 locus allows molecular characterization of four microdeletions and a de novo chromosome X/13 translocation associated with choroideremia. Proceedings of the National Academy of Sciences of the United States of America. 86: 7510-4. PMID 2798422 DOI: 10.1073/Pnas.86.19.7510  0.642
1989 Mariman ECM, Schepens JTG, Wieringa B. Complete nucleotide sequence of the human creatine kinase B gene. Nucleic Acids Research. 17: 6385-6385. PMID 2771648 DOI: 10.1093/Nar/17.15.6385  0.343
1989 Brunner HG, Korneluk RG, Coerwinkel-Driessen M, MacKenzie A, Smeets H, Lambermon HM, van Oost BA, Wieringa B, Ropers HH. Myotonic dystrophy is closely linked to the gene for muscle-type creatine kinase (CKMM). Human Genetics. 81: 308-10. PMID 2703233 DOI: 10.1007/Bf00283680  0.608
1989 Niemann SC, Schonk D, van Dijk P, Wieringa B, Grzeschik KH, Bartels I. Regional localization of the gene encoding pregnancy specific beta-1-glycoprotein 1 (PSBG1) to human chromosome 19q13.1. Cytogenetics and Cell Genetics. 52: 95-7. PMID 2612223 DOI: 10.1159/000132851  0.351
1989 Steeg Hv, Oostrom CTMv, Martens JWM, Kreyl CFv, Schepens J, Wieringa B. Nucleotide sequence of the human ornithine decarboxylase gene. Nucleic Acids Research. 17: 8855-8856. PMID 2587220 DOI: 10.1093/Nar/17.21.8855  0.329
1989 Brunner HG, Smeets H, Lambermon HM, Coerwinkel-Driessen M, van Oost BA, Wieringa B, Ropers HH. A multipoint linkage map around the locus for myotonic dystrophy on chromosome 19. Genomics. 5: 589-95. PMID 2575588 DOI: 10.1016/0888-7543(89)90027-X  0.613
1989 Smeets HJ, Brunner HG, Ropers HH, Wieringa B. Use of variable simple sequence motifs as genetic markers: application to study of myotonic dystrophy. Human Genetics. 83: 245-51. PMID 2571562 DOI: 10.1007/Bf00285165  0.638
1988 Smeets B, Poddighe J, Brunner H, Ropers H, Wieringa B. Tight linkage between myotonic dystrophy and apolipoprotein E genes revealed with allele-specific oligonucleotides. Human Genetics. 80: 49-52. PMID 3417303 DOI: 10.1007/Bf00451455  0.62
1988 Cremers FP, van de Pol TJ, Wieringa B, Hofker MH, Pearson PL, Pfeiffer RA, Mikkelsen M, Tabor A, Ropers HH. Molecular analysis of male-viable deletions and duplications allows ordering of 52 DNA probes on proximal Xq. American Journal of Human Genetics. 43: 452-61. PMID 3177387  0.561
1988 Brunner HG, van Bennekom A, Lambermon EM, Oei TL, Cremers WR, Wieringa B, Ropers HH. The gene for X-linked progressive mixed deafness with perilymphatic gusher during stapes surgery (DFN3) is linked to PGK. Human Genetics. 80: 337-40. PMID 2904400  0.603
1988 Coerwinkel-Driessen M, Schepens J, Zandvoort Pv, Oost Bv, Mariman E, Wieringa B. NcoI RFLP at the creatine kinase-muscle type gene locus (CKMM, chromosome 19). Nucleic Acids Research. 16: 8743-8743. PMID 2901730 DOI: 10.1093/Nar/16.17.8743  0.428
1988 Hulsebos T, Schonk D, van Dalen I, Coerwinkel-Driessen M, Schepens J, Ropers HH, Wieringa B. Isolation and characterization of alphoid DNA sequences specific for the pericentric regions of chromosomes 4, 5, 9, and 19. Cytogenetics and Cell Genetics. 47: 144-8. PMID 2837365 DOI: 10.1159/000132533  0.54
1987 Hulsebos T, Wieringa B, Hochstenbach R, Smeets D, Schepens J, Oerlemans F, Zimmer J, Ropers HH. Toward early diagnosis of myotonic dystrophy: construction and characterization of a somatic cell hybrid with a single human der(19) chromosome. Cytogenetics and Cell Genetics. 43: 47-56. PMID 3502690 DOI: 10.1159/000132297  0.543
1987 Cremers FP, Brunsmann F, van de Pol TJ, Pawlowitzki IH, Paulsen K, Wieringa B, Ropers HH. Deletion of the DXS165 locus in patients with classical choroideremia. Clinical Genetics. 32: 421-3. PMID 3481306  0.531
1987 Davis MB, Schonk D, Monteiro M, Oerlemans F, Povey S, Wieringa B. Localization of PEPD to the long arm of chromosome 19. Annals of Human Genetics. 51: 195-9. PMID 3479944 DOI: 10.1111/J.1469-1809.1987.Tb00871.X  0.329
1987 Cremers FP, Pfeiffer RA, van de Pol TJ, Hofker MH, Kruse TA, Wieringa B, Ropers HH. An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Human Genetics. 77: 23-7. PMID 3476455 DOI: 10.1007/Bf00284707  0.629
1987 Kranen HJv, Zande Lvd, Kreijl CFv, Bisschop A, Wieringa B. Cloning and nucleotide sequence of rat ornithine decarboxylase cDNA. Gene. 60: 145-155. PMID 3443298 DOI: 10.1016/0378-1119(87)90222-8  0.303
1987 Smeets H, Markslag P, Bril J, Hulsebos T, Brunner H, Schonk D, Ropers HH, Wieringa B. EcoRI RFLP at 19 cen-q13.2 identified by the anonymous DNA sequence pPM6.7 (D19S18). Nucleic Acids Research. 15: 8120. PMID 2890138 DOI: 10.1093/Nar/15.19.8120  0.606
1987 Mariman ECM, Schepens J, Kessel AGv, Wieringa B. EcoRI RFLP at the creatine kinase-brain type gene locus (CKBB, chromosome 14). Nucleic Acids Research. 15: 5502-5502. PMID 2885812 DOI: 10.1093/Nar/15.13.5502  0.38
1987 Schepens J, Hulsebos T, Smeets H, Coerwinkel M, Brunner H, Ropers HH, Wieringa B. A locus at 19cen-19q13.2 (D19S15) containing three RFLPs linked to myotonic dystrophy (DM) is recognized by probe pJSB6. Nucleic Acids Research. 15: 3193. PMID 2882485 DOI: 10.1093/Nar/15.7.3193  0.617
1987 Schepens J, Smeets H, Hulsebos T, Brunner H, Wieringa B. Isolation of a polymorphic DNA sequence pJSB11 (D19S16) from the human chromosome 19cen-q13.2 region linked to the myotonic dystrophy (DM) gene. Nucleic Acids Research. 15: 3192-3192. PMID 2882484 DOI: 10.1093/Nar/15.7.3192  0.558
1987 Hulsebos T, Coerwinkel-Driessen M, Wieringa B. RFLPs associated with pMC1, an anonymous single copy clone from the short arm of chromosome 19 [HGM8 assignment no. D19S14]. Nucleic Acids Research. 15: 378-378. PMID 2881255 DOI: 10.1093/Nar/15.1.378  0.352
1986 Hulsebos T, Westphal H, Peek R, Coerwinkel M, Wieringa B. pHW60, an anonymous single copy clone from the proximal portion of the long arm of chromosome 19 (HGM8 assignment no. D19S13). Nucleic Acids Research. 14: 7137-7137. PMID 2876412 DOI: 10.1093/Nar/14.17.7137  0.342
1981 Wieringa B, van der Zwaag-Gerritsen J, Mulder J, Ab G, Gruber M. Translation in vivo and in vitro of mRNAs coding for vitellogenin, serum albumin and very-low-density lipoprotein II from chicken liver. A difference in translational efficiency. European Journal of Biochemistry / Febs. 114: 635-41. PMID 7238505  0.414
1981 Wieringa B, Ab G, Gruber M. The nucleotide sequence of the very low density lipoprotein II mRNA from chicken. Nucleic Acids Research. 9: 489-501. PMID 7012793 DOI: 10.1093/Nar/9.3.489  0.496
1981 Meijlink FC, van het Schip AD, Arnberg AC, Wieringa B, Ab G, Gruber M. Structure of the chicken apo very low density lipoprotein II gene. The Journal of Biological Chemistry. 256: 9668-71. PMID 6270096  0.491
1979 Wieringa B, Roskam W, Arnberg A, van der Zwaag-Gerritsen J, Ab G, Gruber M. Purification of the mRNA for chicken very low density lipoproteinII and molecular cloning of its full-length double-stranded cDNA. Nucleic Acids Research. 7: 2147-63. PMID 230463 DOI: 10.1093/Nar/7.8.2147  0.539
1979 Willems M, Wieringa B, Mulder J, Ab G, Gruber M. Translation of vitellogenin mRNA in the presence of 7-methylguanosine 5'-triphosphate. Cap analogs compete with mRNAs on the basis of affinity for initiation-complex formation. European Journal of Biochemistry / Febs. 93: 469-79. PMID 217682 DOI: 10.1111/J.1432-1033.1979.Tb12845.X  0.407
1978 Wieringa B, Mulder J, van der Ende A, Bruggeman A, Ab G, Gruber M. Purification of vitellogenin mRNA and serum albumin mRNA from avian liver by preparative gel electrophoresis. European Journal of Biochemistry / Febs. 89: 67-79. PMID 699917  0.395
Low-probability matches (unlikely to be authored by this person)
1989 Patterson MN, Bell MV, Bloomfield J, Flint T, Dorkins H, Thibodeau SN, Schaid D, Bren G, Schwartz CE, Wieringa B. Genetic and physical mapping of a novel region close to the fragile X site on the human X chromosome. Genomics. 4: 570-8. PMID 2744766 DOI: 10.1016/0888-7543(89)90281-4  0.3
2005 Streijger F, Oerlemans F, Ellenbroek BA, Jost CR, Wieringa B, Van der Zee CE. Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Behavioural Brain Research. 157: 219-34. PMID 15639173 DOI: 10.1016/j.bbr.2004.07.002  0.299
2015 Venter G, Polling S, Pluk H, Venselaar H, Wijers M, Willemse M, Fransen JA, Wieringa B. Submembranous recruitment of creatine kinase B supports formation of dynamic actin-based protrusions of macrophages and relies on its C-terminal flexible loop. European Journal of Cell Biology. 94: 114-27. PMID 25538032 DOI: 10.1016/j.ejcb.2014.11.002  0.299
1992 Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barceló J, O'Hoy K, Leblond S, Earle-Macdonald J, De Jong PJ, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene Science. 255: 1253-1255. PMID 1546325 DOI: 10.1126/Science.1546325  0.299
2007 van den Broek WJ, Wansink DG, Wieringa B. Somatic CTG*CAG repeat instability in a mouse model for myotonic dystrophy type 1 is associated with changes in cell nuclearity and DNA ploidy. Bmc Molecular Biology. 8: 61. PMID 17645799 DOI: 10.1186/1471-2199-8-61  0.298
1997 Cuppen E, Nagata S, Wieringa B, Hendriks W. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS- like Fas-associated phosphatase-1 in Fas-mediated apoptosis Journal of Biological Chemistry. 272: 30215-30220. PMID 9374505 DOI: 10.1074/jbc.272.48.30215  0.297
1995 de Haan A, Koudijs JC, Wevers RA, Wieringa B. DIFFERENTIAL MUSCLE FATIGUE DURING CONTINUOUS AND REPEATED CONTRACTIONS IN MM-CREATINE KINASE DEFICIENT MICE Medicine & Science in Sports & Exercise. 27: S78. DOI: 10.1249/00005768-199505001-00440  0.296
2007 Heerschap A, Kan HE, Nabuurs CI, Renema WK, Isbrandt D, Wieringa B. In vivo magnetic resonance spectroscopy of transgenic mice with altered expression of guanidinoacetate methyltransferase and creatine kinase isoenzymes. Sub-Cellular Biochemistry. 46: 119-48. PMID 18652075 DOI: 10.1007/978-1-4020-6486-9_7  0.295
1994 van Deursen J, Jap P, Heerschap A, ter Laak H, Ruitenbeek W, Wieringa B. Effects of the creatine analogue β-guanidinopropionic acid on skeletal muscles of mice deficient in muscle creatine kinase Bba - Bioenergetics. 1185: 327-335. PMID 8180237 DOI: 10.1016/0005-2728(94)90248-8  0.294
2003 Renema WK, Schmidt A, van Asten JJ, Oerlemans F, Ullrich K, Wieringa B, Isbrandt D, Heerschap A. MR spectroscopy of muscle and brain in guanidinoacetate methyltransferase (GAMT)-deficient mice: validation of an animal model to study creatine deficiency. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 50: 936-43. PMID 14587004 DOI: 10.1002/Mrm.10627  0.294
1994 van Ree JH, van den Broek WJAA, Dahlmans VEH, Groot PHE, Vidgeon-Hart M, Frants RR, Wieringa B, Havekes LM, Hofker MH. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice Atherosclerosis. 111: 25-37. PMID 7840811 DOI: 10.1016/0021-9150(94)90188-0  0.292
1999 Cuppen E, Van Ham M, Pepers B, Wieringa B, Hendriks W. Identification and molecular characterization of BP75, a novel bromodomain-containing protein Febs Letters. 459: 291-298. PMID 10526152 DOI: 10.1016/S0014-5793(99)01191-6  0.292
1995 de Kok YJM, Geurds MPA, Sistermans EA, Usmany M, Vlak JM, Wieringa B. Production of native creatine kinase B in insect cells using a baculovirus expression vector Molecular and Cellular Biochemistry. 143: 59-65. PMID 7776959 DOI: 10.1007/BF00925927  0.292
1995 Sistermans EA, de Kok YJM, Peters W, Ginsel LA, Jap PHK, Wieringa B. Tissue- and cell-specific distribution of creatine kinase B: A new and highly specific monoclonal antibody for use in immunohistochemistry Cell and Tissue Research. 280: 435-446. PMID 7781040 DOI: 10.1007/BF00307817  0.292
1992 Shutler G, Korneluk RG, Tsilfidis C, Mahadevan M, Bailly J, Smeets H, Jansen G, Wieringa B, Lohman F, Aslanidis C, de Jong PJ. Physical mapping and cloning of the proximal segment of the myotonic dystrophy gene region Genomics. 13: 518-525. PMID 1639380 DOI: 10.1016/0888-7543(92)90119-D  0.292
2009 van Horssen R, Janssen E, Peters W, van de Pasch L, Lindert MM, van Dommelen MM, Linssen PC, Hagen TL, Fransen JA, Wieringa B. Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP exchange capacity. The Journal of Biological Chemistry. 284: 1620-7. PMID 19008233 DOI: 10.1074/jbc.M806974200  0.291
2008 Zhang SJ, Sandström ME, Aydin J, Westerblad H, Wieringa B, Katz A. Activation of glucose transport and AMP-activated protein kinase during muscle contraction in adenylate kinase-1 knockout mice. Acta Physiologica (Oxford, England). 192: 413-20. PMID 17973952 DOI: 10.1111/j.1748-1716.2007.01767.x  0.289
2006 van den Broek WJ, Nelen MR, van der Heijden GW, Wansink DG, Wieringa B. Fen1 does not control somatic hypermutability of the (CTG)(n)*(CAG)(n) repeat in a knock-in mouse model for DM1. Febs Letters. 580: 5208-14. PMID 16978612 DOI: 10.1016/j.febslet.2006.08.059  0.288
2003 van Ham M, Croes H, Schepens J, Fransen J, Wieringa B, Hendriks W. Cloning and characterization of mCRIP2, a mouse LIM-only protein that interacts with PDZ domain IV of PTP-BL. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. 8: 631-44. PMID 12839623 DOI: 10.1046/j.1365-2443.2003.00660.x  0.287
2004 Streijger F, Jost CR, Oerlemans F, Ellenbroek BA, Cools AR, Wieringa B, Van der Zee CE. Mice lacking the UbCKmit isoform of creatine kinase reveal slower spatial learning acquisition, diminished exploration and habituation, and reduced acoustic startle reflex responses. Molecular and Cellular Biochemistry. 256: 305-18. PMID 14977190 DOI: 10.1023/B:Mcbi.0000009877.90129.E3  0.285
2010 Nabuurs C, Huijbregts B, Wieringa B, Hilbers CW, Heerschap A. 31P saturation transfer spectroscopy predicts differential intracellular macromolecular association of ATP and ADP in skeletal muscle. The Journal of Biological Chemistry. 285: 39588-96. PMID 20884612 DOI: 10.1074/Jbc.M110.164665  0.285
2004 de Bruin W, Oerlemans F, Wieringa B. Adenylate kinase I does not affect cellular growth characteristics under normal and metabolic stress conditions. Experimental Cell Research. 297: 97-107. PMID 15194428 DOI: 10.1016/j.yexcr.2004.02.025  0.285
2017 González-Barriga A, Nillessen B, Kranzen J, van Kessel ID, Croes HJ, Aguilera B, de Visser PC, Datson NA, Mulders SA, van Deutekom JC, Wieringa B, Wansink DG. Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro. Nucleic Acid Therapeutics. PMID 28375678 DOI: 10.1089/nat.2016.0641  0.284
2004 Hancock CR, Wieringa B, Terjung R. Metabolic Consequences in Adenine Nucleotides Caused by Adenylate Kinase (AK1-/-) Deficiency During Contractions Medicine & Science in Sports & Exercise. 36: S333. DOI: 10.1097/00005768-200405001-01594  0.284
2007 Dzeja PP, Bast P, Pucar D, Wieringa B, Terzic A. Defective metabolic signaling in adenylate kinase AK1 gene knock-out hearts compromises post-ischemic coronary reflow. The Journal of Biological Chemistry. 282: 31366-72. PMID 17704060 DOI: 10.1074/Jbc.M705268200  0.283
1998 Schaapveld RQJ, Schepens JTG, Bächner D, Attema J, Wieringa B, Jap PHK, Hendriks WJAJ. Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPδ and RPTPσ in the mouse Mechanisms of Development. 77: 59-62. PMID 9784606 DOI: 10.1016/S0925-4773(98)00119-1  0.283
2003 Katz A, Andersson DC, Yu J, Norman B, Sandstrom ME, Wieringa B, Westerblad H. Contraction-mediated glycogenolysis in mouse skeletal muscle lacking creatine kinase: the role of phosphorylase b activation. The Journal of Physiology. 553: 523-31. PMID 12963789 DOI: 10.1113/jphysiol.2003.051078  0.282
1997 Schaapveld R, Wieringa B, Hendriks W. Receptor-like protein tyrosine phosphatases: Alike and yet so different Molecular Biology Reports. 24: 247-262. PMID 9403867 DOI: 10.1023/A:1006870016238  0.282
2000 Dahlstedt AJ, Katz A, Wieringa B, Westerblad H. Is creatine kinase responsible for fatigue? Studies of isolated skeletal muscle deficient in creatine kinase. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 14: 982-90. PMID 10783153 DOI: 10.1096/Fasebj.14.7.982  0.282
2004 Klivenyi P, Calingasan NY, Starkov A, Stavrovskaya IG, Kristal BS, Yang L, Wieringa B, Beal MF. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Neurobiology of Disease. 15: 610-7. PMID 15056469 DOI: 10.1016/J.Nbd.2003.12.014  0.28
1992 Jansen G, Mahadevan M, Amemiya C, Wormskamp N, Segers B, Hendriks W, O'Hoy K, Baird S, Sabourin L, Lennon G, Jap PL, Iles D, Coerwinkel M, Hofker M, Carrano AV, ... ... Wieringa B, et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs Nature Genetics. 1: 261-266. PMID 1302022 DOI: 10.1038/ng0792-261  0.28
1997 Rush JW, Tullson PC, Wieringa B, Terjung RL. SKELETAL MUSCLE CREATINE KINASE DEFICIENCY (MCK-D) INDUCES HIGH AFFINITY AMP DEAMINASE KINETICS 1307 Medicine &Amp Science in Sports &Amp Exercise. 29: 228. DOI: 10.1097/00005768-199705001-01305  0.279
1994 Ree JHV, Wieringa B, Frants RR, Havekes LM, Hofker MH. Molecular genetics of lipid transport in mice; involvement ofApoe-c1-c2 genes Atherosclerosis. 109: 171-172. DOI: 10.1016/0021-9150(94)93692-7  0.279
2009 Kuiper JW, van Horssen R, Oerlemans F, Peters W, van Dommelen MM, te Lindert MM, ten Hagen TL, Janssen E, Fransen JA, Wieringa B. Local ATP generation by brain-type creatine kinase (CK-B) facilitates cell motility. Plos One. 4: e5030. PMID 19333390 DOI: 10.1371/journal.pone.0005030  0.278
2002 Jost CR, Van Der Zee CE, In 't Zandt HJ, Oerlemans F, Verheij M, Streijger F, Fransen J, Heerschap A, Cools AR, Wieringa B. Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility. The European Journal of Neuroscience. 15: 1692-706. PMID 12059977 DOI: 10.1046/J.1460-9568.2002.02001.X  0.277
2012 Yegutkin GG, Wieringa B, Robson SC, Jalkanen S. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 3875-83. PMID 22637533 DOI: 10.1096/fj.12-205658  0.275
1998 Cuppen E, Gerrits H, Pepers B, Wieringa B, Hendriks W. PDZ motifs in PTP-BL and RIL bind to internal protein segments in the LIM domain protein RIL Molecular Biology of the Cell. 9: 671-683. PMID 9487134 DOI: 10.1091/Mbc.9.3.671  0.275
1995 de Haan A, Koudijs JC, Wevers RA, Wieringa B. The effects of MM-creatine kinase deficiency on sustained force production of mouse fast skeletal muscle Experimental Physiology. 80: 491-494. PMID 7640013 DOI: 10.1113/Expphysiol.1995.Sp003863  0.27
2012 Gerrits L, Venselaar H, Wieringa B, Wansink DG, Hendriks WJ. Phosphorylation target site specificity for AGC kinases DMPK E and Lats2. Journal of Cellular Biochemistry. 113: 2126-35. PMID 22492269 DOI: 10.1002/jcb.24086  0.27
1992 Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, Chen C, Alleman J, Wormskamp NGM, Vooijs M, Buxton J, Johnson K, Smeets HJM, Lennon GG, Carrano AV, ... ... Wieringa B, et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect Nature. 355: 548-551. PMID 1346925 DOI: 10.1038/355548A0  0.269
1992 Van Den Hurk JAJM, Van De Pol TJR, Molloy CM, Brunsmann F, Rüther K, Zrenner E, Pinckers AJLG, Pawlowitzki IH, Bleeker-Wagemakers EM, Wieringa B, Ropers HH, Cremers FPM. Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing American Journal of Human Genetics. 50: 1195-1202. PMID 1598901  0.268
2008 Wanschers B, van de Vorstenbosch R, Wijers M, Wieringa B, King SM, Fransen J. Rab6 family proteins interact with the dynein light chain protein DYNLRB1. Cell Motility and the Cytoskeleton. 65: 183-96. PMID 18044744 DOI: 10.1002/cm.20254  0.268
2008 Kuiper JW, Oerlemans FT, Fransen JA, Wieringa B. Creatine kinase B deficient neurons exhibit an increased fraction of motile mitochondria. Bmc Neuroscience. 9: 73. PMID 18662381 DOI: 10.1186/1471-2202-9-73  0.267
2011 Attanasio F, Caldieri G, Giacchetti G, van Horssen R, Wieringa B, Buccione R. Novel invadopodia components revealed by differential proteomic analysis. European Journal of Cell Biology. 90: 115-27. PMID 20609496 DOI: 10.1016/J.Ejcb.2010.05.004  0.266
1998 LaBella JJ, Daood MJ, Koretsky AP, Roman BB, Sieck GC, Wieringa B, Watchko JF. Absence of myofibrillar creatine kinase and diaphragm isometric function during repetitive activation. Journal of Applied Physiology (Bethesda, Md. : 1985). 84: 1166-73. PMID 9516180 DOI: 10.1152/Jappl.1998.84.4.1166  0.266
2010 Mulders SA, van Engelen BG, Wieringa B, Wansink DG. Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function. Human Molecular Genetics. 19: R90-7. PMID 20406734 DOI: 10.1093/hmg/ddq161  0.266
2008 Kuiper JW, Pluk H, Oerlemans F, van Leeuwen FN, de Lange F, Fransen J, Wieringa B. Creatine kinase-mediated ATP supply fuels actin-based events in phagocytosis. Plos Biology. 6: e51. PMID 18336068 DOI: 10.1371/journal.pbio.0060051  0.265
2015 Venter G, Wijers M, Oerlemans FT, Manjeri G, Fransen JA, Wieringa B. Glycolytic Metabolism is Differentially Coupled to Proliferative Potential and Morphodynamic Capacity in RAW 264.7 and Mafb/C-Maf Deficient Macrophage Lineages Journal of Clinical & Cellular Immunology. 6: 1-11. DOI: 10.4172/2155-9899.1000292  0.264
2007 Wanschers BF, van de Vorstenbosch R, Schlager MA, Splinter D, Akhmanova A, Hoogenraad CC, Wieringa B, Fransen JA. A role for the Rab6B Bicaudal-D1 interaction in retrograde transport in neuronal cells. Experimental Cell Research. 313: 3408-20. PMID 17707369 DOI: 10.1016/j.yexcr.2007.05.032  0.264
1996 Tullson PC, Wieringa B, Terjung RL. SKELETAL MUSCLE CREATINE KINASE DEFICIENCY (MCK-D) DECREASES AMP DEAMINASE(AMP-D) ACTIVITY AND APPARENT MOLECULAR WEIGHT 454 Medicine &Amp Science in Sports &Amp Exercise. 28: 76. DOI: 10.1097/00005768-199605001-00454  0.263
1997 Schepens J, Cuppen E, Wieringa B, Hendriks W. The neuronal nitric oxide synthase PDZ motif binds to -G(D,E)XV(*) carboxyterminal sequences Febs Letters. 409: 53-56. PMID 9199503 DOI: 10.1016/S0014-5793(97)00481-X  0.261
1998 ten Dam GB, Poels LG, Wieringa B. Cell surface GPI-anchoring of CD45 isoforms. Molecular Biology Reports. 25: 197-204. PMID 9870608 DOI: 10.1023/A:1006817322524  0.259
1994 Deen PMT, Weghuis DO, van Kessel AG, Wieringa B, van Os CH. The human gene for water channel aquaporin 1 (AQP1) is localized on chromosome 7p15→p14 Cytogenetic and Genome Research. 65: 243-246. PMID 7504987 DOI: 10.1159/000133639  0.259
1995 Van Ree JH, Hofker MH, Van den Broek JAA, Van Deursen JMA, Van der Boom H, Frants RR, Wieringa B, Havekes LM. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice Biochemical Journal. 305: 905-911. PMID 7848292 DOI: 10.1042/Bj3050905  0.258
2000 Watchko JF, Daood MJ, Wieringa B, Koretsky AP. Myofibrillar or mitochondrial creatine kinase deficiency alone does not impair mouse diaphragm isotonic function. Journal of Applied Physiology (Bethesda, Md. : 1985). 88: 973-80. PMID 10710393 DOI: 10.1152/Jappl.2000.88.3.973  0.258
2001 Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR, Hodgson D, Bienengraeber M, Puceat M, Janssen E, Wieringa B, Terzic A. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proceedings of the National Academy of Sciences of the United States of America. 98: 7623-8. PMID 11390963 DOI: 10.1073/Pnas.121038198  0.256
2010 Streijger F, Scheenen WJ, van Luijtelaar G, Oerlemans F, Wieringa B, Van der Zee CE. Complete brain-type creatine kinase deficiency in mice blocks seizure activity and affects intracellular calcium kinetics. Epilepsia. 51: 79-88. PMID 19624717 DOI: 10.1111/j.1528-1167.2009.02182.x  0.255
2020 Xicoy H, Brouwers JF, Wieringa B, Martens GJM. Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson's Disease. Cells. 9. PMID 32858884 DOI: 10.3390/cells9091966  0.254
2014 Venter G, Oerlemans FT, Willemse M, Wijers M, Fransen JA, Wieringa B. NAMPT-mediated salvage synthesis of NAD+ controls morphofunctional changes of macrophages. Plos One. 9: e97378. PMID 24824795 DOI: 10.1371/journal.pone.0097378  0.254
2009 de Groof AJ, te Lindert MM, van Dommelen MM, Wu M, Willemse M, Smift AL, Winer M, Oerlemans F, Pluk H, Fransen JA, Wieringa B. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Molecular Cancer. 8: 54. PMID 19646236 DOI: 10.1186/1476-4598-8-54  0.254
2008 Chang EJ, Ha J, Oerlemans F, Lee YJ, Lee SW, Ryu J, Kim HJ, Lee Y, Kim HM, Choi JY, Kim JY, Shin CS, Pak YK, Tanaka S, Wieringa B, et al. Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nature Medicine. 14: 966-72. PMID 18724377 DOI: 10.1038/Nm.1860  0.25
2000 Cuppen E, van Ham M, Wansink DG, de Leeuw A, Wieringa B, Hendriks W. The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL. European Journal of Cell Biology. 79: 283-93. PMID 10826496 DOI: 10.1078/S0171-9335(04)70031-X  0.25
2000 ten Dam GB, Zilch CF, Wallace D, Wieringa B, Beverley PC, Poels LG, Screaton GR. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. Journal of Immunology (Baltimore, Md. : 1950). 164: 5287-95. PMID 10799890 DOI: 10.4049/Jimmunol.164.10.5287  0.249
1995 Sistermans EA, Klaassen CHW, Peters W, Swarts HGP, Jap PHK, De Pont JJHHM, Wieringa B. Co-localization and functional coupling of creatine kinase B and gastric H+/K+-ATPase on the apical membrane and the tubulovesicular system of parietal cells Biochemical Journal. 311: 445-451. PMID 7487880 DOI: 10.1042/Bj3110445  0.248
2004 Wansink DG, Peters W, Schaafsma I, Sutmuller RP, Oerlemans F, Adema GJ, Wieringa B, van der Zee CE, Hendriks W. Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity. Physiological Genomics. 19: 50-60. PMID 15226483 DOI: 10.1152/physiolgenomics.00079.2004  0.247
1993 Bachinski LL, Krahe R, White BF, Wieringa B, Shaw D, Korneluk R, Thompson LH, Johnson K, Siciliano MJ. An informative panel of somatic cell hybrids for physical mapping on human chromosome 19q. American Journal of Human Genetics. 52: 375-87. PMID 8430698  0.245
2003 Renema WK, Klomp DW, Philippens ME, van den Bergh AJ, Wieringa B, Heerschap A. Magnetization transfer effect on the creatine methyl resonance studied by CW off-resonance irradiation in human skeletal muscle on a clinical MR system. Magnetic Resonance in Medicine. 50: 468-73. PMID 12939753 DOI: 10.1002/Mrm.10564  0.242
1995 van Ree JH, van den Broek WJAA, Dahlmans VEH, Wieringa B, Frants RR, Havekes LM, Hofker MH. Variability in cholesterol content in serum and aortic tissue in apolipoprotein E-deficient mice is comparable in inbred (129/Sv) and outbred (mixed 129/Sv and C57BL/6) mice Atherosclerosis. 118: 165-167. PMID 8579626 DOI: 10.1016/0021-9150(95)05602-S  0.241
2013 van Horssen R, Willemse M, Haeger A, Attanasio F, Güneri T, Schwab A, Stock CM, Buccione R, Fransen JA, Wieringa B. Intracellular NAD(H) levels control motility and invasion of glioma cells. Cellular and Molecular Life Sciences : Cmls. 70: 2175-90. PMID 23307072 DOI: 10.1007/S00018-012-1249-1  0.24
2002 de Groof AJ, Fransen JA, Errington RJ, Willems PH, Wieringa B, Koopman WJ. The creatine kinase system is essential for optimal refill of the sarcoplasmic reticulum Ca2+ store in skeletal muscle. The Journal of Biological Chemistry. 277: 5275-84. PMID 11734556 DOI: 10.1074/jbc.M108157200  0.24
1999 Van Den Maagdenberg AMJM, Schepens JTG, Schepens MTM, Merkx GF, Darroudi F, Wieringa B, Geurts Van Kessel A, Hendriks WJAJ. Assignment of the PTP-SL/PTPBR7 gene (Ptprr/PTPRR) to mouse chromosome region 8A2 by in situ hybridization Cytogenetics and Cell Genetics. 84: 243-244. PMID 10393441  0.24
2013 van Horssen R, Buccione R, Willemse M, Cingir S, Wieringa B, Attanasio F. Cancer cell metabolism regulates extracellular matrix degradation by invadopodia. European Journal of Cell Biology. 92: 113-21. PMID 23306026 DOI: 10.1016/J.Ejcb.2012.11.003  0.239
2019 Xicoy H, Brouwers JF, Kalnytska O, Wieringa B, Martens GJM. Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson's Disease. Molecular Neurobiology. PMID 31493240 DOI: 10.1007/s12035-019-01733-3  0.238
2004 La Spada AR, Richards RI, Wieringa B. Dynamic mutations on the move in Banff. Nature Genetics. 36: 667-70. PMID 15226745 DOI: 10.1038/ng0704-667  0.235
1994 Deen PMT, Weghuis DO, Sinke RJ, van Kessel AG, Wieringa B, van Os CH. Assignment of the human gene for the water channel of renal collecting duct Aquaporin 2 (AQP2) to chromosome 12 region q12→q13 Cytogenetic and Genome Research. 66: 260-262. PMID 7512890 DOI: 10.1159/000133707  0.233
1993 Molhuizen HO, Alkemade HA, Zeeuwen PL, de Jongh GJ, Wieringa B, Schalkwijk J. Purification and molecular characterization of SKALP/elafin, an elastase inhibitor with transglutaminase substrate motifs Journal of Dermatological Science. 6: 30. DOI: 10.1016/0923-1811(93)90904-4  0.232
2008 Pluk H, Croes H, Lich B, Wieringa B, Fransen J. WetSEM: Cell surface characteristics as reporters for cellular energy state Microscopy and Microanalysis. 14: 56-57. DOI: 10.1017/S1431927608082779  0.232
2012 Middelbeek J, Kuipers AJ, Henneman L, Visser D, Eidhof I, van Horssen R, Wieringa B, Canisius SV, Zwart W, Wessels LF, Sweep FC, Bult P, Span PN, van Leeuwen FN, Jalink K. TRPM7 is required for breast tumor cell metastasis. Cancer Research. 72: 4250-61. PMID 22871386 DOI: 10.1158/0008-5472.CAN-11-3863  0.232
1992 Deen PMT, Dempster JA, Wieringa B, Van Os CH. Isolation of a edna for rat CHIP28 water channel: High mRNA expression in kidney cortex and inner medulla Biochemical and Biophysical Research Communications. 188: 1267-1273. PMID 1280133 DOI: 10.1016/0006-291X(92)91368-Z  0.231
2010 Borst JW, Willemse M, Slijkhuis R, van der Krogt G, Laptenok SP, Jalink K, Wieringa B, Fransen JA. ATP changes the fluorescence lifetime of cyan fluorescent protein via an interaction with His148. Plos One. 5: e13862. PMID 21079777 DOI: 10.1371/journal.pone.0013862  0.23
2014 Venter G, Oerlemans FT, Wijers M, Willemse M, Fransen JA, Wieringa B. Glucose controls morphodynamics of LPS-stimulated macrophages. Plos One. 9: e96786. PMID 24796786 DOI: 10.1371/journal.pone.0096786  0.23
1997 Steeghs K, Heerschap A, De Haan A, Ruitenbeek W, Oerlemans F, Van Deursen J, Perryman B, Pette D, Brückwilder M, Koudijs J, Paul J, Wieringa B. Use of gene targeting for compromising energy homeostasis in neuro-muscular tissues: The role of sarcomeric mitochondrial creatine kinase Journal of Neuroscience Methods. 71: 29-41. PMID 9125373 DOI: 10.1016/S0165-0270(96)00124-0  0.226
2000 Ashizawa T, Gonzales I, Ohsawa N, Singer RH, Devillers M, Balasubramanyam A, Cooper TA, Khajavi M, Lia-Baldini AS, Miller G, Philips AV, Timchenko LT, Waring J, Yamagata H, Barbet JP, ... ... Wieringa B, et al. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1) Neurology. 54: 1218-1221. PMID 10746587 DOI: 10.1212/Wnl.54.6.1218  0.225
1998 Van Den Maagdenberg AMJM, Schepens JTG, Schepens MTM, Pepers B, Wieringa B, Geurts Van Kessel A, Hendriks WJAJ. Assignment of Ptprn2,the gene encoding receptor-type protein tyrosine phosphatase IA-2β, a major autoantigen in insulin-dependent diabetes mellitus, to mouse chromosome region 12F Cytogenetics and Cell Genetics. 82: 153-155. PMID 9858807  0.224
2001 Carrasco A, Dzeja P, Alekseev A, Pucar D, Zingman L, Abraham' M, Hodgson D, Bienengraeber M, Puceat M, Janssen E, Wieringa B, Terzic A. Adenylate kinase phosphotransfer communicates cellular energetic signals to KATP channels Journal of Molecular and Cellular Cardiology. 33: A18. DOI: 10.1016/S0022-2828(01)90070-7  0.223
2006 Pelloux S, Chhin B, Ojeda C, Wieringa B, Ovize M, Tourneur Y. Diazoxide increases cytosolic ATP: A new paradigm for preconditioning? Journal of Molecular and Cellular Cardiology. 40: 933. DOI: 10.1016/J.Yjmcc.2006.03.051  0.223
2017 Xicoy H, Wieringa B, Martens GJ. The SH-SY5Y cell line in Parkinson's disease research: a systematic review. Molecular Neurodegeneration. 12: 10. PMID 28118852 DOI: 10.1186/s13024-017-0149-0  0.219
2009 Pluk H, Stokes DJ, Lich B, Wieringa B, Fransen J. Advantages of indium-tin oxide-coated glass slides in correlative scanning electron microscopy applications of uncoated cultured cells. Journal of Microscopy. 233: 353-63. PMID 19250456 DOI: 10.1111/j.1365-2818.2009.03140.x  0.218
2019 Xicoy H, Wieringa B, Martens GJM. The Role of Lipids in Parkinson's Disease. Cells. 8. PMID 30621069 DOI: 10.3390/cells8010027  0.218
2007 Willemse M, Janssen E, de Lange F, Wieringa B, Fransen J. ATP and FRET--a cautionary note. Nature Biotechnology. 25: 170-2. PMID 17287746 DOI: 10.1038/nbt0207-170  0.217
1994 van Deursen J, Wieringa B. Approaching the multifaceted nature of energy metabolism: inactivation of the cytosolic creatine kinases via homologous recombination in mouse embryonic stem cells Molecular and Cellular Biochemistry. 133: 263-274. PMID 7808458 DOI: 10.1007/BF01267959  0.216
2012 Blonsky K, Monckton D, Wieringa B, Schoser B, Day JW, Engelen Bv. 2010 Marigold therapeutic strategies for myotonic dystrophy. Neuromuscular Disorders : Nmd. 22: 87-94. PMID 21852134 DOI: 10.1016/J.Nmd.2011.06.747  0.212
2012 Nabuurs CI, Hilbers CW, Wieringa B, Heerschap A. Letter to the editor: "Interpretation of (31)P NMR saturation transfer experiments: do not forget the spin relaxation properties". American Journal of Physiology. Cell Physiology. 302: C1566-7. PMID 22492653 DOI: 10.1152/Ajpcell.00409.2011  0.201
1994 Jansen G, Willems P, Coerwinkel M, Nillesen W, Smeets H, Vits L, Höweler C, Brunner H, Wieringa B. Gonosomal mosaicism in myotonic dystrophy patients: Involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm American Journal of Human Genetics. 54: 575-585. PMID 8128954  0.2
1998 Tullson PC, Rush JWE, Wieringa B, Terjung RL. Alterations in AMP deaminase activity and kinetics in skeletal muscle of creatine kinase-deficient mice. American Journal of Physiology. Cell Physiology. 274: C1411-C1416. PMID 29591080 DOI: 10.1152/ajpcell.1998.274.5.C1411  0.199
2019 Hendriks WJAJ, Bakker N, Pluk H, de Brouwer A, Wieringa B, Cambi A, Zegers M, Wansink DG, Leunissen R, Klaren PHM. Certainty-based marking in a formative assessment improves student course appreciation but not summative examination scores. Bmc Medical Education. 19: 178. PMID 31151456 DOI: 10.1186/S12909-019-1610-2  0.192
1995 Ventura-Clapier R, Kuznetsov AV, d'Albis A, van Deursen J, Wieringa B, Veksler VI. Muscle creatine kinase-deficient mice. I. Alterations in myofibrillar function. The Journal of Biological Chemistry. 270: 19914-20. PMID 7650006  0.189
1994 Wieringa B. Myotonic dystrophy reviewed: Back to the future? Human Molecular Genetics. 3: 1-7. PMID 8162011 DOI: 10.1093/Hmg/3.1.1-A  0.188
1999 In 'T Zandt HJA, Oerlernans F, Wieringa B, Heerschap A. Effects of ischemia on skeletal muscle energy metabolism in mice lacking creatine kinase monitored by in vivo 31P nuclear magnetic resonance spectroscopy Nmr in Biomedicine. 12: 327-334. PMID 10516614 DOI: 10.1002/(Sici)1099-1492(199910)12:6<327::Aid-Nbm570>3.0.Co;2-9  0.184
1997 Roman BB, Wieringa B, Koretsky AP. Functional equivalence of creatine kinase isoforms in mouse skeletal muscle. The Journal of Biological Chemistry. 272: 17790-4. PMID 9211932 DOI: 10.1074/jbc.272.28.17790  0.182
2002 Pucar D, Bast P, Gumina RJ, Lim L, Drahl C, Juranic N, Macura S, Janssen E, Wieringa B, Terzic A, Dzeja PP. Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion. American Journal of Physiology. Heart and Circulatory Physiology. 283: H776-82. PMID 12124227 DOI: 10.1152/Ajpheart.00116.2002  0.18
1994 Ilees DE, Segers B, Weghuis DO, Suijkerbuijk R, Mikala G, Schwartz A, Wieringa B. Refined Localization of the α1-Subunit of the Skeletal Muscle L-Type Voltage-Dependent Calcium Channel (CACNL1A3) to Human Chromosome 1q32 by in Situ Hybridization Genomics. 19: 561-563. PMID 8188298 DOI: 10.1006/geno.1994.1106  0.177
2003 in 't Zandt HJ, de Groof AJ, Renema WK, Oerlemans FT, Klomp DW, Wieringa B, Heerschap A. Presence of (phospho)creatine in developing and adult skeletal muscle of mice without mitochondrial and cytosolic muscle creatine kinase isoforms. The Journal of Physiology. 548: 847-58. PMID 12640020 DOI: 10.1111/J.1469-7793.2003.00847.X  0.175
1998 In 't Zandt HJA, Wieringa B, Heerschap A. Creatine kinase knockout mice - What is the phenotype: Skeletal muscle Magnetic Resonance Materials in Physics, Biology, and Medicine. 6: 122-123. PMID 9803381 DOI: 10.1016/S1352-8661(98)00036-2  0.166
2004 in 't Zandt HJ, Renema WK, Streijger F, Jost C, Klomp DW, Oerlemans F, Van der Zee CE, Wieringa B, Heerschap A. Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study. Journal of Neurochemistry. 90: 1321-30. PMID 15341516 DOI: 10.1111/J.1471-4159.2004.02599.X  0.16
1994 Van Deursen J, Ruitenbeek W, Heerschap A, Jap P, Ter Laak H, Wieringa B. Creatine kinase (CK) in skeletal muscle energy metabolism: A study of mouse mutants with graded reduction in muscle CK expression Proceedings of the National Academy of Sciences of the United States of America. 91: 9091-9095. PMID 8090775 DOI: 10.1073/Pnas.91.19.9091  0.151
1993 Molhuizen HOF, Alkemade HAC, Zeeuwen PLJM, De Jongh GJ, Wieringa B, Schalkwijk J. SKALP/elafin: An elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking Journal of Biological Chemistry. 268: 12028-12032. PMID 7685029  0.15
1995 Veksler VI, Kuznetsov AV, Anflous K, Mateo P, van Deursen J, Wieringa B, Ventura-Clapier R. Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function. The Journal of Biological Chemistry. 270: 19921-9. PMID 7650007  0.148
1999 Cuppen E, Wijers M, Schepens J, Fransen J, Wieringa B, Hendriks W. A FERM domain governs apical confinement of PTP-BL in epithelial cells Journal of Cell Science. 112: 3299-3308. PMID 10504335  0.147
2006 Wansink DG, Van Herpen RAEMA, Wieringa BA. Normal and pathophysiological significance of myotonic dystrophy protein kinase Genetic Instabilities and Neurological Diseases, Second Edition. 79-97. DOI: 10.1016/B978-012369462-1/50006-5  0.144
2000 in 't Zandt HJ, Klomp DW, Oerlemans F, Wieringa B, Hilbers CW, Heerschap A. Proton MR spectroscopy of wild-type and creatine kinase deficient mouse skeletal muscle: dipole-dipole coupling effects and post-mortem changes. Magnetic Resonance in Medicine. 43: 517-24. PMID 10748426 DOI: 10.1002/(Sici)1522-2594(200004)43:4<517::Aid-Mrm5>3.0.Co;2-I  0.14
2002 Abraham MR, Selivanov VA, Hodgson DM, Pucar D, Zingman LV, Wieringa B, Dzeja PP, Alekseev AE, Terzic A. Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out. The Journal of Biological Chemistry. 277: 24427-34. PMID 11967264 DOI: 10.1074/Jbc.M201777200  0.136
1997 Watchko JF, Daood MJ, Sieck GC, LaBella JJ, Ameredes BT, Koretsky AP, Wieringa B. Combined myofibrillar and mitochondrial creatine kinase deficiency impairs mouse diaphragm isotonic function. Journal of Applied Physiology (Bethesda, Md. : 1985). 82: 1416-23. PMID 9134887 DOI: 10.1152/Jappl.1997.82.5.1416  0.13
1997 Benders AAGM, Groenen PJTA, Oerlemans FTJJ, Veerkamp JH, Wieringa B. Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells Journal of Clinical Investigation. 100: 1440-1447. PMID 9294109  0.126
2000 Kay L, Nicolay K, Wieringa B, Saks V, Wallimann T. Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ Journal of Biological Chemistry. 275: 6937-6944. PMID 10702255 DOI: 10.1074/jbc.275.10.6937  0.117
1997 Cremers FPM, Van Den Hurk JAJM, Hendriks W, Van De Pol TJR, Oerlemans F, Jaissle G, Kohler K, Rütner K, Hartmann J, Zrenner E, Wieringa B, Ropers HH. The choroideremia mutation results in photoreceptor cell degeneration in chimaeric mice but is embryonic lethal in hemizygous mice Faseb Journal. 11: A992.  0.117
2001 Kekelidze T, Khait I, Togliatti A, Benzecry JM, Wieringa B, Holtzman D. Altered brain phosphocreatine and ATP regulation when mitochondrial creatine kinase is absent. Journal of Neuroscience Research. 66: 866-72. PMID 11746413 DOI: 10.1002/jnr.10060  0.112
1999 Heerschap A, Houtman C, in 't Zandt HJ, van den Bergh AJ, Wieringa B. Introduction to in vivo 31P magnetic resonance spectroscopy of (human) skeletal muscle. The Proceedings of the Nutrition Society. 58: 861-70. PMID 10817153  0.11
2003 Wansink DG, Wieringa B. Transgenic mouse models for myotonic dystrophy type 1 (DM1). Cytogenetic and Genome Research. 100: 230-42. PMID 14526185 DOI: 10.1159/000072859  0.109
2003 Schulz PE, McIntosh AD, Kasten MR, Wieringa B, Epstein HF. A role for myotonic dystrophy protein kinase in synaptic plasticity. Journal of Neurophysiology. 89: 1177-86. PMID 12612014 DOI: 10.1152/jn.00504.2002  0.107
2007 Streijger F, Zandt R, Renema KJ, Oerlemans F, Heerschap A, Kuiper J, Pluk H, Jost C, Van Der Zee I, Wieringa B. Developmental and Functional Consequences of Disturbed Energetic Communication in Brain of Creatine Kinase-Deficient Mice: Understanding CK's Role in the Fuelling of Behavior and Learning Molecular System Bioenergetics: Energy For Life. 339-366. DOI: 10.1002/9783527621095.ch10  0.103
1994 Deen PMT, Verdijk MAJ, Knoers NVAM, Wieringa B, Monnens LAH, Van Os CH, Van Oost BA. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine Science. 264: 92-95. PMID 8140421  0.1
2007 Schulze DU, Düfer M, Wieringa B, Krippeit-Drews P, Drews G. An adenylate kinase is involved in KATP channel regulation of mouse pancreatic beta cells. Diabetologia. 50: 2126-34. PMID 17704905 DOI: 10.1007/s00125-007-0742-9  0.095
2000 Driessen CA, Winkens HJ, Hoffmann K, Kuhlmann LD, Janssen BP, Van Vugt AH, Van Hooser JP, Wieringa BE, Deutman AF, Palczewski K, Ruether K, Janssen JJ. Disruption of the 11-cis-retinol dehydrogenase gene leads to accumulation of cis-retinols and cis-retinyl esters. Molecular and Cellular Biology. 20: 4275-87. PMID 10825191 DOI: 10.1128/Mcb.20.12.4275-4287.2000  0.086
1996 Münte TF, Jöbges EM, Wieringa BM, Klein S, Schubert M, Johannes S, Dengler R. Human evoked potentials to long duration vibratory stimuli: role of muscle afferents. Neuroscience Letters. 216: 163-6. PMID 8897483 DOI: 10.1016/0304-3940(96)13036-6  0.078
2002 Johannes S, Wieringa BM, Nager W, Müller-Vahl KR, Dengler R, Münte TF. Excessive action monitoring in Tourette syndrome. Journal of Neurology. 249: 961-6. PMID 12195438 DOI: 10.1007/s00415-002-0657-9  0.072
2001 Johannes S, Wieringa BM, Nager W, Müller-Vahl KR, Dengler R, Münte TF. Electrophysiological measures and dual-task performance in Tourette syndrome indicate deficient divided attention mechanisms. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 8: 253-60. PMID 11328334 DOI: 10.1046/j.1468-1331.2001.00199.x  0.063
1998 Münte TF, Schuppert M, Johannes S, Wieringa BM, Kohlmetz C, Altenmüller E. Brain potentials in patients with music perception deficits: evidence for an early locus. Neuroscience Letters. 256: 85-8. PMID 9853709 DOI: 10.1016/S0304-3940(98)00760-5  0.063
2001 Johannes S, Wieringa BM, Nager W, Rada D, Dengler R, Emrich HM, Münte TF, Dietrich DE. Discrepant target detection and action monitoring in obsessive-compulsive disorder. Psychiatry Research. 108: 101-10. PMID 11738544 DOI: 10.1016/S0925-4927(01)00117-2  0.063
1996 Johannes S, Wieringa BM, Matzke M, Münte TF. Hierarchical visual stimuli: electrophysiological evidence for separate left hemispheric global and local processing mechanisms in humans. Neuroscience Letters. 210: 111-4. PMID 8783285 DOI: 10.1016/0304-3940(96)12686-0  0.061
1996 Watchko JF, Labella JJ, Paood MJ, Koretsky AP, Ameredes BT, Wieringa B. Combined deficiency op myofibrillah and mitochondrial creatine kimask in diaphragm impairs power output during repetitive isotonic contractions Faseb Journal. 10: A2.  0.059
2003 Johannes S, Wieringa BM, Nager W, Rada D, Müller-Vahl KR, Emrich HM, Dengler R, Münte TF, Dietrich D. Tourette syndrome and obsessive-compulsive disorder: event-related brain potentials show similar mechanisms [correction of mechansims] of frontal inhibition but dissimilar target evaluation processes. Behavioural Neurology. 14: 9-17. PMID 12719634 DOI: 10.1155/2003/326468  0.056
2000 Schuppert M, Münte TF, Wieringa BM, Altenmüller E. Receptive amusia: evidence for cross-hemispheric neural networks underlying music processing strategies. Brain : a Journal of Neurology. 123: 546-59. PMID 10686177 DOI: 10.1093/brain/123.3.546  0.054
1998 Münte TF, Heinze HJ, Matzke M, Wieringa BM, Johannes S. Brain potentials and syntactic violations revisited: no evidence for specificity of the syntactic positive shift. Neuropsychologia. 36: 217-26. PMID 9622187 DOI: 10.1016/S0028-3932(97)00119-X  0.054
1999 Schiltz K, Trocha K, Wieringa BM, Emrich HM, Johannes S, Münte TF. Neurophysiological aspects of synesthetic experience. The Journal of Neuropsychiatry and Clinical Neurosciences. 11: 58-65. PMID 9990557 DOI: 10.1176/Jnp.11.1.58  0.05
2002 Rüsseler J, Kowalczuk J, Johannes S, Wieringa BM, Münte TF. Cognitive brain potentials to novel acoustic stimuli in adult dyslexic readers. Dyslexia (Chichester, England). 8: 125-42. PMID 12222730 DOI: 10.1002/dys.221  0.05
1997 Münte TF, Ridao-Alonso ME, Preinfalk J, Jung A, Wieringa BM, Matzke M, Dengler R, Johannes S. An electrophysiological analysis of altered cognitive functions in Huntington disease. Archives of Neurology. 54: 1089-98. PMID 9311352  0.048
1999 Münte TF, Tröger MC, Nusser I, Wieringa BM, Matzke M, Johannes S, Dengler R. Abnormalities of visual search behaviour in ALS patients detected with event-related brain potentials. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 1: 21-7. PMID 12365064 DOI: 10.1080/146608299300079493  0.047
2001 Kohlmetz C, Altenmüller E, Schuppert M, Wieringa BM, Münte TF. Deficit in automatic sound-change detection may underlie some music perception deficits after acute hemispheric stroke. Neuropsychologia. 39: 1121-4. PMID 11527548 DOI: 10.1016/S0028-3932(01)00079-3  0.046
1998 Schlitz K, Trocha K, Wieringa BM, Emrich HM, Johannes S, Munte TF. Electrophysiological findings in synesthesia | Elektrophysiologische befunde bei der synasthesie Klinische Neurophysiologie. 29: 29-36.  0.046
1997 Johannes S, Kube C, Wieringa BM, Matzke M, Münte TF. Brain potentials and time estimation in humans. Neuroscience Letters. 231: 63-6. PMID 9291141 DOI: 10.1016/S0304-3940(97)00529-6  0.045
2001 Johannes S, Wieringa BM, Mantey M, Nager W, Rada D, Müller-Vahl KR, Emrich HM, Dengler R, Münte TF, Dietrich D. Altered inhibition of motor responses in Tourette Syndrome and Obsessive-Compulsive Disorder. Acta Neurologica Scandinavica. 104: 36-43. PMID 11442441 DOI: 10.1034/J.1600-0404.2001.00308.X  0.045
2010 Thorns J, Wieringa BM, Mohammadi B, Hammer A, Dengler R, Münte TF. Movement initiation and inhibition are impaired in amyotrophic lateral sclerosis. Experimental Neurology. 224: 389-94. PMID 20435037 DOI: 10.1016/j.expneurol.2010.04.014  0.045
1997 Münte TF, Brack M, Grootheer O, Wieringa BM, Matzke M, Johannes S. Event-related brain potentials to unfamiliar faces in explicit and implicit memory tasks. Neuroscience Research. 28: 223-33. PMID 9237270 DOI: 10.1016/S0168-0102(97)00047-3  0.044
1998 Münte TF, Brack M, Grootheer O, Wieringa BM, Matzke M, Johannes S. Brain potentials reveal the timing of face identity and expression judgments. Neuroscience Research. 30: 25-34. PMID 9572577 DOI: 10.1016/S0168-0102(97)00118-1  0.044
2003 Müller SV, Johannes S, Wieringa B, Weber A, Müller-Vahl K, Matzke M, Kolbe H, Dengler R, Münte TF. Disturbed monitoring and response inhibition in patients with Gilles de la Tourette syndrome and co-morbid obsessive compulsive disorder. Behavioural Neurology. 14: 29-37. PMID 12719636  0.043
1998 Münte TF, Tröger MC, Nusser I, Wieringa BM, Johannes S, Matzke M, Dengler R. Alteration of early components of the visual evoked potential in amyotrophic lateral sclerosis. Journal of Neurology. 245: 206-10. PMID 9591221 DOI: 10.1007/s004150050206  0.042
1997 Münte TF, Szentkuti A, Wieringa BM, Matzke M, Johannes S. Human brain potentials to reading syntactic errors in sentences of different complexity. Neuroscience Letters. 235: 105-8. PMID 9406880 DOI: 10.1016/S0304-3940(97)00719-2  0.042
2000 Dietrich DE, Emrich HM, Waller C, Wieringa BM, Johannes S, Münte TF. Emotion/cognition-coupling in word recognition memory of depressive patients: an event-related potential study. Psychiatry Research. 96: 15-29. PMID 10980323 DOI: 10.1016/S0165-1781(00)00187-6  0.041
2001 Münte TF, Wieringa BM, Weyerts H, Szentkuti A, Matzke M, Johannes S. Differences in brain potentials to open and closed class words: class and frequency effects. Neuropsychologia. 39: 91-102. PMID 11115658 DOI: 10.1016/S0028-3932(00)00095-6  0.04
2000 Dietrich DE, Kleinschmidt A, Hauser U, Schneider U, Spannhuth CW, Kipp K, Huber TJ, Wieringa BM, Emrich HM, Johannes S. Word recognition memory before and after successful treatment of depression. Pharmacopsychiatry. 33: 221-8. PMID 11147930 DOI: 10.1055/S-2000-8358  0.037
2001 Johannes S, Wieringa BM, Nager W, Dengler R, Münte TF. Oxazepam alters action monitoring. Psychopharmacology. 155: 100-6. PMID 11374327 DOI: 10.1007/s002130100680  0.037
2003 Rüsseler J, Johannes S, Kowalczuk J, Wieringa BM, Münte TF. Developmental dyslexics show altered allocation of attention in visual classification tasks. Acta Neurologica Scandinavica. 107: 22-30. PMID 12542509 DOI: 10.1034/j.1600-0404.2003.02060.x  0.032
2001 Dietrich DE, Waller C, Johannes S, Wieringa BM, Emrich HM, Münte TF. Differential effects of emotional content on event-related potentials in word recognition memory. Neuropsychobiology. 43: 96-101. PMID 11174053 DOI: 10.1159/000054874  0.03
1997 Wieringa B. Alteration of early components of the visual event related potential in amyotrophic lateral sclerosis Electroencephalography and Clinical Neurophysiology. 103: 150. DOI: 10.1016/s0013-4694(97)88687-0  0.03
1998 Münte TF, Tröger M, Nusser I, Wieringa BM, Matzke M, Johannes S, Dengler R. Recognition memory deficits in amyotrophic lateral sclerosis assessed with event-related brain potentials. Acta Neurologica Scandinavica. 98: 110-5. PMID 9724008  0.029
1994 Wieringa B. Commentary: Myotonic dystrophy reviewed: Back to the future? Human Molecular Genetics. 3: 1-7.  0.028
1998 Schubert M, Johannes S, Koch M, Wieringa BM, Dengler R, Münte TF. Differential effects of two motor tasks on ERPs in an auditory classification task: evidence of shared cognitive resources. Neuroscience Research. 30: 125-34. PMID 9579646 DOI: 10.1016/S0168-0102(97)00115-6  0.025
1997 Munte TF, Schwirtz O, Wieringa BM, Matzke M, Johannes S. Electrophysiology of complex sentences: word and sentence-level ERPs | Elektrophysiologie komplexer Satze: Ereigniskorrelierte Potentiale auf der Wort- und Satzebene Eeg-Emg Zeitschrift Fur Elektroenzephalographie Elektromyographie Und Verwandte Gebiete. 28: 11-17.  0.016
Hide low-probability matches.